Author

N. Wall

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Approach:statistical model· 1

Frequent Co-Authors

A. C. Marquez· 1 shared A. F. Cunningham· 1 shared A. Jasiulewicz· 1 shared A. N. Jassem· 1 shared A. Richter· 1 shared B. Grunau· 1 shared C. MacDonald· 1 shared D. M. Goldfarb· 1 shared

Activity by Year

2022-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. C. Marquez

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Different vaccine platforms result in distinct antibody responses to the same antigen in haemodialysis patients

N. Wall, R. Lamerton, F. Ashford, M. Perez-Toledo, A. Jasiulewicz, G. Banham, M. L. Newby, S. E. Faustini, A. Richter, H. Selvaskandan, R. Billany, S. Adenwalla, I. R. Henderson, M. Crispin, M. Graham-Brown, , A. F. Cunningham

This study compares antibody responses in haemodialysis patients after vaccination with different platforms, finding mRNA vaccines induce better functional responses than viral vectors.

bioRxiv · Jan 14, 2024 · PreprintImmunology

Determining the optimal SARS-CoV-2 mRNA vaccine dosing interval for maximum immunogenicity

M. Asamoah-Boaheng, D. M. Goldfarb, M. Prusinkiewicz, L. Golding, M. E. Karim, V. Barakauskas, N. Wall, A. N. Jassem, A. C. Marquez, C. MacDonald, S. F. O'Brien, P. Lavoie, B. Grunau

This study finds that longer SARS-CoV-2 vaccine dosing intervals (≥30 days) are associated with higher antibody concentrations and viral neutralization at 6 months post-first dose.

bioRxiv · Mar 1, 2022Microbiology